Global Diabetes Management Market, by Device Type (Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices), by Therapeutics (Injectables, Oral Drugs), and Geography Forecast to 2026

Market Scenario

Diabetes management market size was valued at USD 12.7 billion in 2016 and is projected to reach to USD 61.59 billion at a CAGR of 17.2%. This is a comprehensive global report focused on the current and future prospects of the diabetes management market. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the diabetes management market has been done in order to calculate the growth rates for each segments and sub-segments. Diabetes management market Rising prevalence of diabetes is anticipated to fuel the demand for diabetes management devices and antidiabetic drugs Growing geriatric population, worldwide rising prevalence of diabetes, increasing uptake of novel drugs such as incretin & dipeptidyl inhibitors, technological advancements in diabetes devices, and the presence of government initiatives are factors attributed to the market growth over the forecast period.In addition, increasing prevalence of obesity and growing preference for combination therapy across the world is expected to assist in the market growth. Geriatric population is prone to develop diabetes. According to data provided by the World Health Organization (WHO), the global population aged 60 years and above is anticipated to rise from 841.0 million in 2013 to over 2.0 billion by 2050.WHO further reported that the number of diabetic patients has increased from 108.0 million in 1980 to 422.0 million in 2014. This disease is anticipated be the seventh leading cause of death by 2030. On the contrary, high cost of devices and therapeutics is expected to hinder the market growth over the forecast period. The blood glucose meters, a leading device segment in the diabetes management market On the basis of monitoring device type, the blood glucose meters segment is expected to dominate the market during the forecast period due to increasing need of blood glucose level monitoring in order to manage diabetes effectively. The injectables segment is expected to spearhead the market in next ten years On the basis of therapeutics, the injectables segment is anticipated to hold major chunk of the diabetes management market in near future owing to rising preference for insulin from patients. The dipeptidyl inhibitors segment is expected to register comparatively higher market growth owing to its safe nature and once daily dose regimen. diabetes management market A surge in the number of obese and diabetics in BRICS countries is anticipated to support the market growth over the forecast period Geographically, BRICS countries are expected to hold major share of the market owing to growing geriatric population and increasing incidences of diabetes in Brazil, Russia, India, China, and South Africa. America is also expected to grab substantial market share in next ten years attributed to changing lifestyle of individuals and rising prevalence of diabetes & obesity in the U.S., Canada, and Mexico. Collaboration of pharmaceutical and medical device manufacturers to put diabetes management market on high growth trajectory Major players in this vertical have implemented growth strategies such as new product launch, partnership, collaboration, operational expansion, and merger & acquisition. For instance, in July 2017, ZydusCadila launched Sitagliptin (50 mg/500mg) and Metformin Hydrochloride (50 mg/1000mg) tablets in the U.S. Key Highlights: • Global diabetes management market size analysis and forecast • Comprehensive study and analysis of market drivers, restraints, and opportunities influencing growth of the global diabetes management market • Diabetes management market segmentation on the basis of device type, therapeutics, and geography (regional) • Diabetes management market strategic analysis with respect to individual growth trends, future prospects along with contribution of various sub-market stakeholders have been considered under the scope of study • Diabetes management market analysis and forecast for five major regions such as Americas, Europe except BRICS, Asia Pacific except BRICS, MEA except BRICS, and BRICS countries • Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies • Competitive landscape of the key players operating in the diabetes management market including competitive developments, investments, and strategic expansion Years that have been considered for the study are as follows: • Base Year – 2016 • Estimated Year – 2017 • Forecast Period – 2017 to 2026 For company profiles, 2016 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered. Research Methodology: The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get unbiased idea of the market. This exercise was done at country level to get fair idea of the market in countries considered for this study. Later this country specific data was accumulated to come up with regional numbers and then arrive at global market value for diabetes management market. diabetes management market Some of the key players of the diabetes management market include: • Bayer Healthcare AG • ZydusCadila • BD • Bristol-Myers Squibb Company • Sanofi • Merck & Co. Inc. • F. Hoffmann-La Roche Ltd • Eli Lilly And Company • Novo Nordisk A/S • Medtronic • Insulet Corporation • LifeScan, Inc. Key Target Audience: • Manufacturers in end-use industries • Diabetes management device & drug manufacturers • Investors and financial community professionals • Manufacturing technology providers • Diabetes management device & drug providers • Industry associations • Raw material suppliers • Government agencies • Market research and consulting firms Scope of the Report: The research report segments the diabetes management market based on device type, therapeutics, and geography. Diabetes Management Market, By Device Type: • Monitoring Devices • Blood Glucose Meters • Blood Sampling Devices • Lancets • Diagnostic Devices • Hemoglobin A1c Kits • Hemoglobin A1c Meters • Insulin Delivery Devices • Insulin Pens • Insulin Pumps • Insulin Syringes • Others • Diabetes Monitoring Software • Artificial Pancreas Systems Diabetes Management Market, By Therapeutics: • Injectables • Insulin • Exenatide • Oral Drugs • Metformin • Sulfonylureas • Alpha-glucosidase Inhibitors • Dipeptidyl Inhibitors •  Thaizolidinediones • Meglitinides • Combination Medications Diabetes Management Market, By Geography: • Americas • North America • U.S. • Canada o Latin America Except BRICS • Mexico • Argentina • Chile • Rest of Latin America Except BRICS • Europe Except BRICS • UK • Germany •  France • Italy • Spain •  Sweden • Norway • Netherlands • Rest of Europe Except BRICS • Asia Pacific Except BRICS • Japan • Australia • Singapore • Malaysia • Vietnam • New Zealand • Rest of Asia Pacific Except BRICS • MEA Except BRICS • GCC • Turkey • Israel • Rest of MEA Except BRICS • BRICS • Brazil • Russia • India • China •  South Africa Geographic Analysis: • Breakdown of Americas diabetes management market • Breakdown of Europe except BRICS diabetes management market • Breakdown of Asia Pacific except BRICS diabetes management market • Breakdown of MEA except BRICS diabetes management market • Breakdown of BRICS diabetes management market Available Customizations: Maximize Market Research offers customizations of reports according to the specific requirement of our clients Stem Cell Therapy Market Report expected to reach 202.77 billion by 2026

Table of Contents

1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET VARIABLES & SCOPE 3.1. Market Segmentation & Scope 3.2. Market Driver Analysis 3.3. Market Restraint Analysis 3.4. Penetration &Growth Prospect Mapping 3.5. Market SWOT Analysis, By Factor (political & legal, economic and technological) 3.6. Porter’s Five Forces Industry Analysis 3.7. Market Value Chain Analysis 4. DEVICE TYPE ESTIMATES & TREND ANALYSIS (2016 – 2026) 4.1. Diabetes Management Market: Device Type Movement Analysis 4.2. Monitoring Devices 4.2.1. Monitoring devices market, 2016 – 2026 (USD million) 4.2.2. Blood glucose meters 4.2.2.1. Blood glucose meters market, 2016 – 2026 (USD million) 4.2.3. Blood sampling devices 4.2.3.1. Blood sampling devices market, 2016 – 2026 (USD million) 4.2.4. Lancets 4.2.4.1. Lancets market, 2016 – 2026 (USD million) 4.3. Diagnostic Devices 4.3.1. Diagnostic devices market, 2016 – 2026 (USD million) 4.3.2. Hemoglobin A1c kits 4.3.2.1. Hemoglobin A1c kits market, 2016 – 2026 (USD million) 4.3.3. Hemoglobin A1c Meters 4.3.3.1. Hemoglobin A1c meters market, 2016 – 2026 (USD million) 4.4. Insulin Delivery Devices 4.4.1. Insulin delivery devices market, 2016 – 2026 (USD million) 4.4.2. Insulin pens 4.4.2.1. Insulin pens market, 2016 – 2026 (USD million) 4.4.3. Insulin pumps 4.4.3.1. Insulin pumps market, 2016 – 2026 (USD million) 4.4.4. Insulin syringes 4.4.4.1. Insulin syringes market, 2016 – 2026 (USD million) 4.5. Others 4.5.1. Others market, 2016 – 2026 (USD million) 4.5.2. Diabetes monitoring software 4.5.2.1. Diabetes monitoring software market, 2016 – 2026 (USD million) 4.5.3. Artificial pancreas systems 4.5.3.1. Artificial pancreas systems market, 2016 – 2026 (USD million) 5. THERAPEUTICSESTIMATES & TREND ANALYSIS (2016 – 2026) 5.1. Diabetes Management Market: Therapeutics Movement Analysis 5.2. Injectables 5.2.1. Injectablesmarket, 2016 – 2026 (USD million) 5.2.2. Insulin 5.2.2.1. Insulin market, 2016 – 2026 (USD million) 5.2.3. Exenatide 5.2.3.1. Exenatide market, 2016 – 2026 (USD million) 5.3. Oral Drugs 5.3.1. Oral drugs market, 2016 – 2026 (USD million) 5.3.2. Metformin 5.3.2.1. Metformin market, 2016 – 2026 (USD million) 5.3.3. Sulfonylureas 5.3.3.1. Sulphonylureas market, 2016 – 2026 (USD million) 5.3.4. Alpha-glucosidase inhibitors 5.3.4.1. Alpha-glucosidase market, 2016 – 2026 (USD million) 5.3.5. Dipeptidyl inhibitors 5.3.5.1. Dipeptidyl inhibitors market, 2016 – 2026 (USD million) 5.3.6. Thaizolidinediones 5.3.6.1. Thiazolidinediones market, 2016 – 2026 (USD million) 5.3.7. Meglitinides 5.3.7.1. Meglitinides market, 2016 – 2026 (USD million) 5.3.8. Combination medications 5.3.8.1. Combination medicationsmarket, 2016 – 2026 (USD million) 6. REGIONAL ESTIMATES & TREND ANALYSIS BY DEVICE TYPE AND THERAPEUTICS(2016 – 2026) 6.1. Diabetes management market share by region, 2016 & 2025 6.2. Americas 6.2.1. Americas diabetes management market, 2016 – 2026 (USD million) 6.2.2. North America 6.2.2.1. North America diabetes management market, 2016 – 2026 (USD million) 6.2.2.2. U.S. 6.2.2.2.1. U.S. diabetes management market, 2016 – 2026 (USD million) 6.2.2.3. Canada 6.2.2.3.1. Canada diabetes management market, 2016 – 2026 (USD million) 6.2.3. Latin America except BRICS 6.2.3.1. Latin America except BRICS diabetes management market, 2016 – 2026 (USD million) 6.2.3.2. Mexico 6.2.3.2.1. Mexico diabetes management market, 2016 – 2026 (USD million) 6.2.3.3. Argentina 6.2.3.3.1. Argentina diabetes management market, 2016 – 2026 (USD million) 6.2.3.4. Chile 6.2.3.4.1. Chile diabetes management market, 2016 – 2026 (USD million) 6.2.3.5. Rest of Latin America except BRICS 6.2.3.5.1. Rest of Latin America except BRICS diabetes management market, 2016 – 2026 (USD million) 6.3. Europe Except BRICS 6.3.1. Europe except BRICS diabetes management market, 2016 – 2026 (USD million) 6.3.2. UK 6.3.2.1. UK diabetes management market, 2016 – 2026 (USD million) 6.3.3. Germany 6.3.3.1. Germany diabetes management market, 2016 – 2026 (USD million) 6.3.4. France 6.3.4.1. France diabetes management market, 2016 – 2026 (USD million) 6.3.5. Italy 6.3.5.1. Italy diabetes management market, 2016 – 2026 (USD million) 6.3.6. Spain 6.3.6.1. Spain diabetes management market, 2016 – 2026 (USD million) 6.3.7. Sweden 6.3.7.1. Sweden diabetes management market, 2016 – 2026 (USD million) 6.3.8. Norway 6.3.8.1. Norway diabetes management market, 2016 – 2026 (USD million) 6.3.9. Netherlands 6.3.9.1. Netherlands diabetes management market, 2016 – 2026 (USD million) 6.3.10. Rest of Europe except BRICS 6.3.10.1. Rest of Europe except BRICS diabetes management market, 2016 – 2026 (USD million) 6.4. Asia Pacific Except BRICS 6.4.1. Asia Pacific except BRICS diabetes management market, 2016 – 2026 (USD million) 6.4.2. Japan 6.4.2.1. Japan diabetes management market, 2016 – 2026 (USD million) 6.4.3. Australia 6.4.3.1. Australia diabetes management market, 2016 – 2026 (USD million) 6.4.4. Singapore 6.4.4.1. Singapore diabetes management market, 2016 – 2026 (USD million) 6.4.5. Malaysia 6.4.5.1. Malaysia diabetes management market, 2016 – 2026 (USD million) 6.4.6. Vietnam 6.4.6.1. Vietnam diabetes management market, 2016 – 2026 (USD million) 6.4.7. New Zealand 6.4.7.1. New Zealand diabetes management market, 2016 – 2026 (USD million) 6.4.8. Rest of Asia Pacific except BRICS 6.4.8.1. Rest of Asia Pacific except BRICS diabetes management market, 2016 – 2026 (USD million) 6.5. MEA Except BRICS 6.5.1. MEA except BRICS diabetes management market, 2016 – 2026 (USD million) 6.5.2. GCC 6.5.2.1. GCC diabetes management market, 2016 – 2026 (USD million) 6.5.3. Turkey 6.5.3.1. Turkey diabetes management market, 2016 – 2026 (USD million) 6.5.4. Israel 6.5.4.1. Israel diabetes management market, 2016 – 2026 (USD million) 6.5.5. Rest of MEA except BRICS 6.5.5.1. Rest of except BRICS diabetes management market, 2016 – 2026 (USD million) 6.6. BRICS 6.6.1. BRICS diabetes management market, 2016 – 2026 (USD million) 6.6.2. Brazil 6.6.2.1. Brazil diabetes management market, 2016 – 2026 (USD million) 6.6.3. Russia 6.6.3.1. Russia diabetes management market, 2016 – 2026 (USD million) 6.6.4. India 6.6.4.1. India diabetes management market, 2016 – 2026 (USD million) 6.6.5. China 6.6.5.1. China diabetes management market, 2016 – 2026 (USD million) 6.6.6. South Africa 6.6.6.1. South Africa diabetes management market, 2016 – 2026 (USD million) 7. MARKET COMPETITION ANALYSIS 7.1. Strategy Framework 7.2. Company Profiles 7.2.1. Bayer Healthcare AG 7.2.1.1. Company Overview 7.2.1.2. Financial Performance 7.2.1.3. Product Benchmarking 7.2.1.4. Strategic Initiatives 7.2.2. ZydusCadila 7.2.2.1. Company Overview 7.2.2.2. Financial Performance 7.2.2.3. Product Benchmarking 7.2.2.4. Strategic Initiatives 7.2.3. BD 7.2.3.1. Company Overview 7.2.3.2. Financial Performance 7.2.3.3. Product Benchmarking 7.2.3.4. Strategic Initiatives 7.2.4. Bristol-Myers Squibb Company 7.2.4.1. Company Overview 7.2.4.2. Financial Performance 7.2.4.3. Product Benchmarking 7.2.4.4. Strategic Initiatives 7.2.5. Sanofi 7.2.5.1. Company Overview 7.2.5.2. Financial Performance 7.2.5.3. Product Benchmarking 7.2.5.4. Strategic Initiatives 7.2.6. Merck & Co. Inc. 7.2.6.1. Company Overview 7.2.6.2. Financial Performance 7.2.6.3. Product Benchmarking 7.2.6.4. Strategic Initiatives 7.2.7. F. Hoffmann-La Roche Ltd 7.2.7.1. Company Overview 7.2.7.2. Financial Performance 7.2.7.3. Product Benchmarking 7.2.7.4. Strategic Initiatives 7.2.8. Eli Lilly And Company 7.2.8.1. Company Overview 7.2.8.2. Financial Performance 7.2.8.3. Product Benchmarking 7.2.8.4. Strategic Initiatives 7.2.9. Novo Nordisk A/S 7.2.9.1. Company Overview 7.2.9.2. Financial Performance 7.2.9.3. Product Benchmarking 7.2.9.4. Strategic Initiatives 7.2.10. Medtronic 7.2.10.1. Company Overview 7.2.10.2. Financial Performance 7.2.10.3. Product Benchmarking 7.2.10.4. Strategic Initiatives 7.2.11. Insulet Corporation 7.2.11.1. Company Overview 7.2.11.2. Financial Performance 7.2.11.3. Product Benchmarking 7.2.11.4. Strategic Initiatives 7.2.12. LifeScan, Inc. 7.2.12.1. Company Overview 7.2.12.2. Financial Performance 7.2.12.3. Product Benchmarking 7.2.12.4. Strategic Initiatives LIST OF TABLES Table 1 Americas diabetes management market, by device type, 2016 – 2026 (USD million) Table 2 Americas diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 3 North America diabetes management market, by device type, 2016 – 2026(USD million) Table 4 North America diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 5 U.S. diabetes management market, by device type, 2016 – 2026 (USD million) Table 6 U.S. diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 7 Canada diabetes management market, by device type, 2016 – 2026 (USD million) Table 8 Canada diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 9 Latin Americaexcept BRICS diabetes management market, by device type, 2016 – 2026 (USD million) Table 10 Latin America except BRICS diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 11 Mexico diabetes management market, by device type, 2016 – 2026 (USD million) Table 12 Mexico diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 13 Argentina diabetes management market, by device type, 2016 – 2026 (USD million) Table 14 Argentina diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 15 Chile diabetes management market, by device type, 2016 – 2026 (USD million) Table 16 Chile diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 17 Rest of Latin Americaexcept BRICS diabetes management market, by device type, 2016 – 2026 (USD million) Table 18 Rest of Latin Americaexcept BRICS diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 19 Europe except BRICS diabetes management market, by device type, 2016 – 2026 (USD million) Table 20 Europe except BRICS diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 21 UK diabetes management market, by device type, 2016 – 2026 (USD million) Table 22 UK diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 23 Germany diabetes management market, by device type, 2016 – 2026 (USD million) Table 24 Germany diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 25 France diabetes management market, by device type, 2016 – 2026 (USD million) Table 26 France diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 27 Italy diabetes management market, by device type, 2016 – 2026 (USD million) Table 28 Italy diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 29 Spain diabetes management market, by device type, 2016 – 2026 (USD million) Table 30 Spain diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 31 Sweden diabetes management market, by device type, 2016 – 2026 (USD million) Table 32 Sweden diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 33 Norway diabetes management market, by device type, 2016 – 2026 (USD million) Table 34 Norway diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 35 Netherlands diabetes management market, by device type, 2016 – 2026 (USD million) Table 36 Netherlands diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 37 Rest of Europe except BRICS diabetes management market, by device type, 2016 – 2026 (USD million) Table 38 Rest of Europe except BRICS diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 39 Asia Pacific except BRICS diabetes management market, by device type, 2016 – 2026 (USD million) Table 40 Asia Pacific except BRICS diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 41 Japan diabetes management market, by device type, 2016 – 2026 (USD million) Table 42 Japan diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 43 Australia diabetes management market, by device type, 2016 – 2026 (USD million) Table 44 Australia diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 45 Singapore diabetes management market, by device type, 2016 – 2026 (USD million) Table 46 Singapore diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 47 Malaysia diabetes management market, by device type, 2016 – 2026 (USD million) Table 48 Malaysia diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 49 Vietnam diabetes management market, by device type, 2016 – 2026 (USD million) Table 50 Vietnam diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 51 New Zealand diabetes management market, by device type, 2016 – 2026 (USD million) Table 52 New Zealand diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 53 Rest of Asia Pacific except BRICS diabetes management market, by device type, 2016 – 2026 (USD million) Table 54 Rest of Asia Pacific except BRICS diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 55 MEA except BRICS diabetes management market, by device type, 2016 – 2026 (USD million) Table 56 MEA except BRICS diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 57 GCC diabetes management market, by device type, 2016 – 2026 (USD million) Table 58 GCC diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 59 Turkey diabetes management market, by device type, 2016 – 2026 (USD million) Table 60 Turkey diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 61 Israel diabetes management market, by device type, 2016 – 2026 (USD million) Table 62 Israel diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 63 Rest of MEA except BRICS diabetes management market, by device type, 2016 – 2026 (USD million) Table 64 Rest of MEA except BRICS diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 65 BRICS diabetes management market, by device type, 2016 – 2026 (USD million) Table 66 BRICS diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 67 Brazil diabetes management market, by device type, 2016 – 2026 (USD million) Table 68 Brazil diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 69 Russia diabetes management market, by device type, 2016 – 2026 (USD million) Table 70 Russia diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 71 India diabetes management market, by device type, 2016 – 2026 (USD million) Table 72 India diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 73 China diabetes management market, by device type, 2016 – 2026 (USD million) Table 74 China diabetes management market, by therapeutics, 2016 – 2026 (USD million) Table 75 South Africa diabetes management market, by device type, 2016 – 2026 (USD million) Table 76 South Africa diabetes management market, by therapeutics, 2016 – 2026 (USD million) LIST OF FIGURES Figure. 1 Market summary Figure. 2 Market segmentation & scope Figure. 3 Market driver relevance analysis (Current & future impact) Figure. 4 Market restraint relevance analysis (Current & future Impact) Figure. 5 Penetration & growth prospect mapping Figure. 6 Diabetes management market PEST by SWOT analysis Figure. 7 Porter’s Five Forces analysis Figure. 8 Diabetes management market device type outlook: Key takeaways Figure. 9 Diabetes management market: Device type movement analysis Figure. 10 Monitoring devices market,2016 – 2026 (USD million) Figure. 11 Blood glucose meters market,2016 – 2026 (USD million) Figure. 12 Blood sampling devices market,2016 – 2026 (USD million) Figure. 13 Lancets market,2016 – 2026 (USD million) Figure. 14 Diagnostic devices market,2016 – 2026 (USD million) Figure. 15 Hemoglobin A1c kits market,2016 – 2026 (USD million) Figure. 16 Hemoglobin A1c meters market,2016 – 2026 (USD million) Figure. 17 Insulin delivery devices market,2016 – 2026 (USD million) Figure. 18 Insulin pens market,2016 – 2026 (USD million) Figure. 19 Insulin pumps market,2016 – 2026 (USD million) Figure. 20 Insulin syringes market,2016 – 2026 (USD million) Figure. 21 Others market,2016 – 2026 (USD million) Figure. 22 Diabetes monitoring software market,2016 – 2026 (USD million) Figure. 23 Artificial pancreas systems market,2016 – 2026 (USD million) Figure. 24 Diabetes management market therapeutics outlook: Key takeaways Figure. 25 Diabetes management market: Therapeutics movement analysis Figure. 26 Injectables market,2016 – 2026 (USD million) Figure. 27 Insulin market,2016 – 2026 (USD million) Figure. 28 Exenatide market,2016 – 2026 (USD million) Figure. 29 Oral drugs market,2016 – 2026 (USD million) Figure. 30 Metformin market,2016 – 2026 (USD million) Figure. 31 Sulfonylureas market,2016 – 2026 (USD million) Figure. 32 Alpha-glucosidase inhibitors market,2016 – 2026 (USD million) Figure. 33 Dipeptidyl inhibitors market,2016 – 2026 (USD million) Figure. 34 Thaizolidinediones market,2016 – 2026 (USD million) Figure. 35 Meglitinides market,2016 – 2026 (USD million) Figure. 36 Combination medications market, 2016 – 2026 (USD million) Figure. 37 Regional market place: Key takeaways Figure. 38 Regional outlook, 2016 & 2026 Figure. 39 Americas diabetes management market, 2016 – 2026 (USD million) Figure. 40 North America diabetes management market, 2016 – 2026 (USD million) Figure. 41 U.S.diabetes management market, 2016 – 2026 (USD million) Figure. 42 Canada diabetes management market, 2016 – 2026 (USD million) Figure. 43 Latin America diabetes management market, 2016 – 2026 (USD million) Figure. 44 Mexico diabetes management market, 2016 – 2026 (USD million) Figure. 45 Argentina diabetes management market, 2016 – 2026 (USD million) Figure. 46 Chile diabetes management market, 2016 – 2026 (USD million) Figure. 47 Rest of Latin America diabetes management market, 2016 – 2026 (USD million) Figure. 48 Europe except BRICS diabetes management market, 2016 – 2026 (USD million) Figure. 49 UK diabetes management market, 2016 – 2026 (USD million) Figure. 50 Germany diabetes management market, 2016 – 2026 (USD million) Figure. 51 France diabetes management market, 2016 – 2026 (USD million) Figure. 52 Italy diabetes management market, 2016 – 2026 (USD million) Figure. 53 Spain diabetes management market, 2016 – 2026 (USD million) Figure. 54 Sweden diabetes management market, 2016 – 2026 (USD million) Figure. 55 Norway diabetes management market, 2016 – 2026 (USD million) Figure. 56 Netherlands diabetes management market, 2016 – 2026 (USD million) Figure. 57 Rest of Europe except BRICS diabetes management market, 2016 – 2026 (USD million) Figure. 58 Asia Pacific except BRICS diabetes management market, 2016 – 2026 (USD million) Figure. 59 Japan diabetes management market, 2016 – 2026 (USD million) Figure. 60 Australia diabetes management market, 2016 – 2026 (USD million) Figure. 61 Singapore diabetes management market, 2016 – 2026 (USD million) Figure. 62 Malaysia diabetes management market, 2016 – 2026 (USD million) Figure. 63 Vietnam diabetes management market, 2016 – 2026 (USD million) Figure. 64 New Zealand diabetes management market, 2016 – 2026 (USD million) Figure. 65 Rest of Asia Pacific except BRICS diabetes management market, 2016 – 2026 (USD million) Figure. 66 MEA except BRICS diabetes management market, 2016 – 2026 (USD million) Figure. 67 GCC diabetes management market, 2016 – 2026 (USD million) Figure. 68 Turkey diabetes management market, 2016 – 2026 (USD million) Figure. 69 Israel diabetes management market, 2016 – 2026 (USD million) Figure. 70 Rest of MEA except BRICS diabetes management market, 2016 – 2026 (USD million) Figure. 71 BRICS diabetes management market, 2016 – 2026 (USD million) Figure. 72 Brazil diabetes management market, 2016 – 2026 (USD million) Figure. 73 Russia diabetes management market, 2016 – 2026 (USD million) Figure. 74 India diabetes management market, 2016 – 2026 (USD million) Figure. 75 China diabetes management market, 2016 – 2026 (USD million) Figure. 76 South Africa diabetes management market, 2016 – 2026 (USD million) Figure. 77 Strategy framework

Inquiry Before Buying

Request Sample

About This Report

Report ID 1114
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now